MS AI Stock Analysis – Buy, Hold, or Avoid?
Morgan Stanley (MS)
Fundamentals
Morgan Stanley (MS) demonstrates strong financial health characterized by robust revenue and earnings growth, improving profitability metrics, and consistent outperformance in quarterly earnings. The company's diversified business model and strong market position underpin its resilience and ability to deliver attractive returns. However, valuation appears fair rather than deeply undervalued, and macro/market risks remain salient.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
11.08% YoY
Q4 2025
Net Income
18.39% YoY
Q4 2025
Net Margin
Q4 2025
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q4 2025
Net Income Growth YoY
Latest Quarter: Q4 2025
Revenue Per Share Growth YoY
Latest Quarter: Q4 2025
EPS Growth YoY
Latest Quarter: Q4 2025
Book Value Per Share Growth YoY
Latest Quarter: Q4 2025
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9B | 30.0B | 28.2B | 27.9B | 26.0B | 26.3B | 25.5B | 25.3B |
| Revenue Growth YoY | +11.08% | +14.13% | +10.50% | +10.11% | +7.40% | +16.67% | +18.62% | +19.18% |
| Net Income | 4.4B | 4.6B | 3.5B | 4.3B | 3.7B | 3.2B | 3.1B | 3.4B |
| Net Income Growth YoY | +18.39% | +44.60% | +15.05% | +26.47% | +144.83% | +32.39% | +40.97% | +14.50% |
| EPS | $2.71 | $2.83 | $2.15 | $2.62 | $2.25 | $1.91 | $1.85 | $2.04 |
| EPS Growth YoY | +20.44% | +48.17% | +16.22% | +28.43% | +161.63% | +37.41% | +48.00% | +18.60% |
Profitability Metrics
Technical Analysis
Morgan Stanley (MS) is currently in a strong upward trend with price well above key moving averages, confirming a bullish technical setup. The RSI indicates neutral momentum, suggesting room for further gains without being overbought. However, the ADX reflects a weaker trend strength, indicating some range-bound behavior may coexist within the broader uptrend.
No extreme reading
Price in uptrend
Range-bound market
50 above 200 - bullish
Key Technical Values
Price with Moving Averages
50-day, 150-day and 200-day simple moving averages
Relative Strength Index
Momentum oscillator measuring speed and magnitude of price changes
RSI (14)
Earnings
Morgan Stanley (MS) demonstrates strong financial health characterized by robust revenue and earnings growth, improving profitability metrics, and consistent outperformance in quarterly earnings. The company's diversified business model and strong market position underpin its resilience and ability to deliver attractive returns. However, valuation appears fair rather than deeply undervalued, and macro/market risks remain salient.
Latest Earnings
Q4 2025 Earnings (Dec 31, 2025)
Earnings Per Share (EPS)
Actual
$2.68
Estimated
$2.43
Surprise
+$0.25
Surprise %
+10.29%
Revenue
Actual
$17.89B
Estimated
$17.74B
Surprise
+$148.84M
Surprise %
+0.84%
Historical Earnings
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share | ||||||||
| EPS (Actual) | $2.68 | $2.80 | $2.13 | $2.60 | $2.22 | $1.88 | $1.82 | $2.02 |
| EPS (Estimated) | $2.43 | $2.10 | $1.98 | $2.21 | $1.62 | $1.58 | $1.65 | $1.66 |
| EPS Surprise | +$0.25 | +$0.70 | +$0.15 | +$0.39 | +$0.60 | +$0.30 | +$0.17 | +$0.36 |
| % Diff | +10.3% | +33.3% | +7.6% | +17.6% | +37.0% | +19.0% | +10.3% | +21.7% |
| Revenue | ||||||||
| Revenue (Actual) | $17.89B | $17.08B | $15.6B | $16.52B | $15.04B | $14.34B | $14.02B | $14.22B |
| Revenue (Estimated) | $17.74B | $16.69B | $16.07B | $16.54B | $15.03B | $14.35B | $14.32B | $14.4B |
| Revenue Surprise | +$148.84M | +$394.92M | -$461.94M | -$20.16M | +$16.73M | -$12.25M | -$297.77M | -$185.09M |
| % Diff | +0.8% | +2.4% | -2.9% | -0.1% | +0.1% | -0.1% | -2.1% | -1.3% |
Valuation
Morgan Stanley currently trades at a valuation level that reflects moderate earnings growth and sector leadership in financial services. Analyst sentiment is mixed to positive, with price targets suggesting a modest upside potential, influenced by the firm's strategic positioning amid evolving market themes such as AI and geopolitical shifts. Overall, the valuation reflects a balance between growth prospects and sector risks.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 15.86 | 13.54 | 15.69 | 10.71 | 13.40 | 12.98 | 12.85 | 10.97 |
| Price to Sales | 9.66 | 8.31 | 7.89 | 6.62 | 7.66 | 6.29 | 6.20 | 5.91 |
| Price to Book | 2.50 | 2.27 | 2.05 | 1.73 | 1.90 | 1.60 | 1.57 | 1.51 |
| Enterprise Value to EBITDA | 93.18 | 80.11 | 92.76 | 81.28 | 73.85 | 87.13 | 85.12 | 83.58 |
| Enterprise Value to Revenue | 22.27 | 19.66 | 19.53 | 18.66 | 18.62 | 18.17 | 17.85 | 17.71 |
Sentiment & Analyst Ratings
Morgan Stanley (MS) currently exhibits a balanced sentiment profile with a tilt toward optimism. Analysts show a mixed-to-positive view with a majority rating the stock as Hold or Buy and price targets suggesting moderate upside potential. News highlights strong earnings expectations, AI-driven growth prospects, and new product launches that underpin constructive investor sentiment, although market volatility and geopolitical risks temper enthusiasm.
Analyst Recommendations
Risk Assessment
Morgan Stanley presents a moderate financial risk profile with liquidity improving sharply in the latest quarter but solvency metrics indicating high leverage typical for a financial institution. Regulatory issues from recent SEC settlements and FINRA oversight increase compliance risk, while competition across investment banking and wealth management remains intense. Market dynamics are favorable with an anticipated bull market driven by AI investments, but macro and geopolitical risks persist.
Liquidity & Solvency
Frequently Asked Questions about MS
AI Answers: Common Questions About MS
Get AI-powered answers to the questions investors ask most about Morgan Stanley
Morgan Stanley is a good buy for long-term investors, trading at a P/E of 17.4 (below historical highs) and showing robust EPS growth (30% YoY). While the stock is near resistance and fairly valued, its sector leadership and improving margins support further appreciation, especially on pullbacks or confirmed breakouts.
Unless your thesis has changed or you need to rebalance, there is little reason to sell now. Fundamentals remain strong, technicals are bullish above key moving averages, and upcoming catalysts (earnings, new products) could drive further gains. Only consider trimming if the stock fails to break out above $180 or if regulatory risks escalate.
The biggest risks are high leverage (debt-to-equity >4, interest coverage <1), ongoing regulatory scrutiny (recent SEC/FINRA settlements), and sensitivity to macro/geopolitical shocks. While liquidity has improved (current ratio 1.17), the capital-intensive nature of the business means risks must be monitored closely.
Near-term resistance is at $180 and the 52-week high of $192.68, which serves as a realistic price target. Analysts see modest upside from current levels ($177.64), with intermediate support at $169 and $162. A confirmed breakout above $180 could target the $192–$195 range.
Morgan Stanley is fairly valued: its P/E (17.4) and price-to-book are above sector averages but justified by superior growth and margins. EV/EBITDA is elevated due to leverage, but not excessive given the earnings trajectory. There is no evidence of significant overvaluation.
Fundamentals are strong: revenue up 11.4% YoY, EPS up 30% YoY, net income margin at 14.7%, and operating margin at 19.1%. Wealth management and recurring fee income provide stability, and liquidity has improved (current ratio 1.17).
Technically, MS is in a bullish uptrend above the 50/200 SMAs (golden cross), with RSI at 66.7 (neutral, not overbought). Immediate resistance is $180, with support at $169/$162. A breakout above $180 could trigger a run toward $192.68.
Key catalysts include the Q1 2026 earnings report (expected strong growth), the launch of the Bitcoin Trust ETF, and continued AI-driven product innovation. Macro events (rate changes, geopolitical shifts) and regulatory developments also warrant close attention.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.